Cargando…
Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
The underlying molecular mechanisms and evolutionary patterns of lung cancer metastasis remain unclear, resulting in a lack of effective indicators for early diagnosis of metastasis. We retrospectively analyzed 117 patients with primary non-small cell lung cancer (NSCLC) admitted to Tongji Hospital...
Autores principales: | Zhang, Wei, Wang, Weiwei, Wu, Junlu, Tian, Jiale, Yan, Wenhui, Yuan, Yi, Yao, Yiwen, Shang, Anquan, Quan, Wenqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638068/ https://www.ncbi.nlm.nih.gov/pubmed/36353553 http://dx.doi.org/10.3389/fonc.2022.942964 |
Ejemplares similares
-
Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022) -
Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer
por: Sun, Zujun, et al.
Publicado: (2021) -
GTPBP4: A New Therapeutic Target Gene Promotes Tumor Progression in Non-Small Cell Lung Cancer via EMT
por: Wu, Junlu, et al.
Publicado: (2022) -
Retinoic Acid-Induced Gene G(RIG-G) as a Novel Monitoring Biomarker in Leukemia and Its Clinical Applications
por: Wang, Fei, et al.
Publicado: (2021) -
Immune Infiltration of Ulcerative Colitis and Detection of the m6A Subtype
por: Gu, Chenzheng, et al.
Publicado: (2022)